The global market for Polidocanol Injection was valued at US$ 81.0 million in the year 2024 and is projected to reach a revised size of US$ 134 million by 2031, growing at a CAGR of 7.4% during the forecast period.

Polidocanol Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Polidocanol Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Polidocanol injection is a therapeutic drug primarily used in sclerotherapy to address varicose veins and spider veins.

Polidocanol Injection is a widely used non-ionic surfactant-based sclerosing agent indicated primarily for the treatment of varicose veins, telangiectasias, and vascular malformations. Its mechanism of action involves direct endothelial damage upon intravascular injection, leading to endothelial cell disruption, thrombus formation, vessel fibrosis, and eventual occlusion. Polidocanol’s dual functionality as a detergent and anesthetic-like agent makes it highly favorable in modern sclerotherapy, especially when compared to older agents like hypertonic saline or absolute ethanol, which often cause significant pain and tissue irritation.

From a clinical and safety perspective, Polidocanol stands out for its low incidence of adverse reactions, including minimal injection-site pain, low risk of necrosis, and rare systemic events when properly administered. It is FDA-approved for the treatment of incompetent varicose veins and is considered the agent of choice in both liquid and foam sclerotherapy. Foam formulations, created by mixing the solution with air or gas, enhance the surface area contact within the vein, reduce dilution by blood, and allow treatment of larger veins with reduced volume, improving efficacy and reducing recurrence rates.

In regulatory and commercial terms, Polidocanol Injection is included in treatment guidelines across the US, Europe, and parts of Asia. The market is dominated by key formulations like Asclera® (Merz Pharmaceuticals) in the US and Aethoxysklerol® (Kreussler Pharma) in Europe, both backed by substantial clinical data. Generic versions are increasingly available, especially in markets with established procedural use of sclerotherapy in dermatology, phlebology, and cosmetic medicine. Its use has expanded beyond varicose veins to include vascular anomalies in children, hemorrhoid sclerotherapy, and adjunctive use in minimally invasive cosmetic procedures.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polidocanol Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polidocanol Injection.

The Polidocanol Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polidocanol Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polidocanol Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Polidocanol Injection Market Report

Report Metric	Details
Report Name	Polidocanol Injection Market
Accounted market size in year	US$ 81.0 million
Forecasted market size in 2031	US$ 134 million
CAGR	7.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	10mg per Unit 20mg per Unit 60mg per Unit
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Kreussler Pharma, Saintroy Lifesciences, Ocean Pharmaceutical, SGPharma, Hebei Renhe Yikang Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Aetos Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polidocanol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polidocanol Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Polidocanol Injection Market growing?

Ans: The Polidocanol Injection Market witnessing a CAGR of 7.4% during the forecast period 2025-2031.

What is the Polidocanol Injection Market size in 2031?

Ans: The Polidocanol Injection Market size in 2031 will be US$ 134 million.

Who are the main players in the Polidocanol Injection Market report?

Ans: The main players in the Polidocanol Injection Market are Kreussler Pharma, Saintroy Lifesciences, Ocean Pharmaceutical, SGPharma, Hebei Renhe Yikang Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Aetos Pharma

What are the Application segmentation covered in the Polidocanol Injection Market report?

Ans: The Applications covered in the Polidocanol Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Polidocanol Injection Market report?

Ans: The Types covered in the Polidocanol Injection Market report are 10mg per Unit, 20mg per Unit, 60mg per Unit

1 Polidocanol Injection Market Overview

1.1 Product Definition

1.2 Polidocanol Injection by Type

1.2.1 Global Polidocanol Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 10mg per Unit

1.2.3 20mg per Unit

1.2.4 60mg per Unit

1.3 Polidocanol Injection by Application

1.3.1 Global Polidocanol Injection Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Polidocanol Injection Market Size Estimates and Forecasts

1.4.1 Global Polidocanol Injection Revenue 2020-2031

1.4.2 Global Polidocanol Injection Sales 2020-2031

1.4.3 Global Polidocanol Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Polidocanol Injection Market Competition by Manufacturers

2.1 Global Polidocanol Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Polidocanol Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Polidocanol Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Polidocanol Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Polidocanol Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Polidocanol Injection, Product Type & Application

2.7 Global Key Manufacturers of Polidocanol Injection, Date of Enter into This Industry

2.8 Global Polidocanol Injection Market Competitive Situation and Trends

2.8.1 Global Polidocanol Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Polidocanol Injection Players Market Share by Revenue

2.8.3 Global Polidocanol Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Polidocanol Injection Market Scenario by Region

3.1 Global Polidocanol Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Polidocanol Injection Sales by Region: 2020-2031

3.2.1 Global Polidocanol Injection Sales by Region: 2020-2025

3.2.2 Global Polidocanol Injection Sales by Region: 2026-2031

3.3 Global Polidocanol Injection Revenue by Region: 2020-2031

3.3.1 Global Polidocanol Injection Revenue by Region: 2020-2025

3.3.2 Global Polidocanol Injection Revenue by Region: 2026-2031

3.4 North America Polidocanol Injection Market Facts & Figures by Country

3.4.1 North America Polidocanol Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Polidocanol Injection Sales by Country (2020-2031)

3.4.3 North America Polidocanol Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Polidocanol Injection Market Facts & Figures by Country

3.5.1 Europe Polidocanol Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Polidocanol Injection Sales by Country (2020-2031)

3.5.3 Europe Polidocanol Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Polidocanol Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Polidocanol Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Polidocanol Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Polidocanol Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Polidocanol Injection Market Facts & Figures by Country

3.7.1 Latin America Polidocanol Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Polidocanol Injection Sales by Country (2020-2031)

3.7.3 Latin America Polidocanol Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Polidocanol Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Polidocanol Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Polidocanol Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Polidocanol Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Polidocanol Injection Sales by Type (2020-2031)

4.1.1 Global Polidocanol Injection Sales by Type (2020-2025)

4.1.2 Global Polidocanol Injection Sales by Type (2026-2031)

4.1.3 Global Polidocanol Injection Sales Market Share by Type (2020-2031)

4.2 Global Polidocanol Injection Revenue by Type (2020-2031)

4.2.1 Global Polidocanol Injection Revenue by Type (2020-2025)

4.2.2 Global Polidocanol Injection Revenue by Type (2026-2031)

4.2.3 Global Polidocanol Injection Revenue Market Share by Type (2020-2031)

4.3 Global Polidocanol Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Polidocanol Injection Sales by Application (2020-2031)

5.1.1 Global Polidocanol Injection Sales by Application (2020-2025)

5.1.2 Global Polidocanol Injection Sales by Application (2026-2031)

5.1.3 Global Polidocanol Injection Sales Market Share by Application (2020-2031)

5.2 Global Polidocanol Injection Revenue by Application (2020-2031)

5.2.1 Global Polidocanol Injection Revenue by Application (2020-2025)

5.2.2 Global Polidocanol Injection Revenue by Application (2026-2031)

5.2.3 Global Polidocanol Injection Revenue Market Share by Application (2020-2031)

5.3 Global Polidocanol Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Kreussler Pharma

6.1.1 Kreussler Pharma Company Information

6.1.2 Kreussler Pharma Description and Business Overview

6.1.3 Kreussler Pharma Polidocanol Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Kreussler Pharma Polidocanol Injection Product Portfolio

6.1.5 Kreussler Pharma Recent Developments/Updates

6.2 Saintroy Lifesciences

6.2.1 Saintroy Lifesciences Company Information

6.2.2 Saintroy Lifesciences Description and Business Overview

6.2.3 Saintroy Lifesciences Polidocanol Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Saintroy Lifesciences Polidocanol Injection Product Portfolio

6.2.5 Saintroy Lifesciences Recent Developments/Updates

6.3 Ocean Pharmaceutical

6.3.1 Ocean Pharmaceutical Company Information

6.3.2 Ocean Pharmaceutical Description and Business Overview

6.3.3 Ocean Pharmaceutical Polidocanol Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Ocean Pharmaceutical Polidocanol Injection Product Portfolio

6.3.5 Ocean Pharmaceutical Recent Developments/Updates

6.4 SGPharma

6.4.1 SGPharma Company Information

6.4.2 SGPharma Description and Business Overview

6.4.3 SGPharma Polidocanol Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 SGPharma Polidocanol Injection Product Portfolio

6.4.5 SGPharma Recent Developments/Updates

6.5 Hebei Renhe Yikang Pharmaceutical

6.5.1 Hebei Renhe Yikang Pharmaceutical Company Information

6.5.2 Hebei Renhe Yikang Pharmaceutical Description and Business Overview

6.5.3 Hebei Renhe Yikang Pharmaceutical Polidocanol Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Hebei Renhe Yikang Pharmaceutical Polidocanol Injection Product Portfolio

6.5.5 Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates

6.6 Chia Tai Tianqing Pharmaceutical

6.6.1 Chia Tai Tianqing Pharmaceutical Company Information

6.6.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.6.3 Chia Tai Tianqing Pharmaceutical Polidocanol Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Chia Tai Tianqing Pharmaceutical Polidocanol Injection Product Portfolio

6.6.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

6.7 Aetos Pharma

6.7.1 Aetos Pharma Company Information

6.7.2 Aetos Pharma Description and Business Overview

6.7.3 Aetos Pharma Polidocanol Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Aetos Pharma Polidocanol Injection Product Portfolio

6.7.5 Aetos Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Polidocanol Injection Industry Chain Analysis

7.2 Polidocanol Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Polidocanol Injection Production Mode & Process Analysis

7.4 Polidocanol Injection Sales and Marketing

7.4.1 Polidocanol Injection Sales Channels

7.4.2 Polidocanol Injection Distributors

7.5 Polidocanol Injection Customer Analysis

8 Polidocanol Injection Market Dynamics

8.1 Polidocanol Injection Industry Trends

8.2 Polidocanol Injection Market Drivers

8.3 Polidocanol Injection Market Challenges

8.4 Polidocanol Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Kreussler Pharma

Saintroy Lifesciences

Ocean Pharmaceutical

SGPharma

Hebei Renhe Yikang Pharmaceutical

Chia Tai-Tianqing Pharmaceutical

Aetos Pharma

List of Tables

Table 1. Global Polidocanol Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Polidocanol Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Polidocanol Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Polidocanol Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Polidocanol Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Polidocanol Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Polidocanol Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Polidocanol Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Polidocanol Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Polidocanol Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Polidocanol Injection, Product Type & Application

Table 12. Global Key Manufacturers of Polidocanol Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Polidocanol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polidocanol Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Polidocanol Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Polidocanol Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Polidocanol Injection Sales Market Share by Region (2020-2025)

Table 19. Global Polidocanol Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Polidocanol Injection Sales Market Share by Region (2026-2031)

Table 21. Global Polidocanol Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Polidocanol Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Polidocanol Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Polidocanol Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Polidocanol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Polidocanol Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Polidocanol Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Polidocanol Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Polidocanol Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Polidocanol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Polidocanol Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Polidocanol Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Polidocanol Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Polidocanol Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Polidocanol Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Polidocanol Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Polidocanol Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Polidocanol Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Polidocanol Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Polidocanol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Polidocanol Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Polidocanol Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Polidocanol Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Polidocanol Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Polidocanol Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Polidocanol Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Polidocanol Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Polidocanol Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Polidocanol Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Polidocanol Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Polidocanol Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Polidocanol Injection Sales Market Share by Type (2020-2025)

Table 53. Global Polidocanol Injection Sales Market Share by Type (2026-2031)

Table 54. Global Polidocanol Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Polidocanol Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Polidocanol Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Polidocanol Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Polidocanol Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Polidocanol Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Polidocanol Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Polidocanol Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Polidocanol Injection Sales Market Share by Application (2020-2025)

Table 63. Global Polidocanol Injection Sales Market Share by Application (2026-2031)

Table 64. Global Polidocanol Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Polidocanol Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Polidocanol Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Polidocanol Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Polidocanol Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Polidocanol Injection Price (US$/Unit) by Application (2026-2031)

Table 70. Kreussler Pharma Company Information

Table 71. Kreussler Pharma Description and Business Overview

Table 72. Kreussler Pharma Polidocanol Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Kreussler Pharma Polidocanol Injection Product

Table 74. Kreussler Pharma Recent Developments/Updates

Table 75. Saintroy Lifesciences Company Information

Table 76. Saintroy Lifesciences Description and Business Overview

Table 77. Saintroy Lifesciences Polidocanol Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Saintroy Lifesciences Polidocanol Injection Product

Table 79. Saintroy Lifesciences Recent Developments/Updates

Table 80. Ocean Pharmaceutical Company Information

Table 81. Ocean Pharmaceutical Description and Business Overview

Table 82. Ocean Pharmaceutical Polidocanol Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Ocean Pharmaceutical Polidocanol Injection Product

Table 84. Ocean Pharmaceutical Recent Developments/Updates

Table 85. SGPharma Company Information

Table 86. SGPharma Description and Business Overview

Table 87. SGPharma Polidocanol Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. SGPharma Polidocanol Injection Product

Table 89. SGPharma Recent Developments/Updates

Table 90. Hebei Renhe Yikang Pharmaceutical Company Information

Table 91. Hebei Renhe Yikang Pharmaceutical Description and Business Overview

Table 92. Hebei Renhe Yikang Pharmaceutical Polidocanol Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Hebei Renhe Yikang Pharmaceutical Polidocanol Injection Product

Table 94. Hebei Renhe Yikang Pharmaceutical Recent Developments/Updates

Table 95. Chia Tai Tianqing Pharmaceutical Company Information

Table 96. Chia Tai Tianqing Pharmaceutical Description and Business Overview

Table 97. Chia Tai Tianqing Pharmaceutical Polidocanol Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Chia Tai Tianqing Pharmaceutical Polidocanol Injection Product

Table 99. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

Table 100. Aetos Pharma Company Information

Table 101. Aetos Pharma Description and Business Overview

Table 102. Aetos Pharma Polidocanol Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Aetos Pharma Polidocanol Injection Product

Table 104. Aetos Pharma Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Polidocanol Injection Distributors List

Table 108. Polidocanol Injection Customers List

Table 109. Polidocanol Injection Market Trends

Table 110. Polidocanol Injection Market Drivers

Table 111. Polidocanol Injection Market Challenges

Table 112. Polidocanol Injection Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Polidocanol Injection

Figure 2. Global Polidocanol Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Polidocanol Injection Market Share by Type: 2024 & 2031

Figure 4. 10mg per Unit Product Picture

Figure 5. 20mg per Unit Product Picture

Figure 6. 60mg per Unit Product Picture

Figure 7. Global Polidocanol Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Polidocanol Injection Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Polidocanol Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Polidocanol Injection Market Size (2020-2031) & (US$ Million)

Figure 14. Global Polidocanol Injection Sales (2020-2031) & (K Units)

Figure 15. Global Polidocanol Injection Average Price (US$/Unit) & (2020-2031)

Figure 16. Polidocanol Injection Report Years Considered

Figure 17. Polidocanol Injection Sales Share by Manufacturers in 2024

Figure 18. Global Polidocanol Injection Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Polidocanol Injection Players: Market Share by Revenue in Polidocanol Injection in 2024

Figure 20. Polidocanol Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Polidocanol Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Polidocanol Injection Sales Market Share by Country (2020-2031)

Figure 23. North America Polidocanol Injection Revenue Market Share by Country (2020-2031)

Figure 24. United States Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Polidocanol Injection Sales Market Share by Country (2020-2031)

Figure 27. Europe Polidocanol Injection Revenue Market Share by Country (2020-2031)

Figure 28. Germany Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Polidocanol Injection Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Polidocanol Injection Revenue Market Share by Region (2020-2031)

Figure 35. China Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Polidocanol Injection Sales Market Share by Country (2020-2031)

Figure 43. Latin America Polidocanol Injection Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Polidocanol Injection Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Polidocanol Injection Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Polidocanol Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Polidocanol Injection by Type (2020-2031)

Figure 54. Global Revenue Market Share of Polidocanol Injection by Type (2020-2031)

Figure 55. Global Polidocanol Injection Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Polidocanol Injection by Application (2020-2031)

Figure 57. Global Revenue Market Share of Polidocanol Injection by Application (2020-2031)

Figure 58. Global Polidocanol Injection Price (US$/Unit) by Application (2020-2031)

Figure 59. Polidocanol Injection Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions